Autoantibodies specific for idiopathic inflammatory myopathy (myositis-specific
autoantibodies (MSAs)) are clinically useful biomarkers to help the diagnosis of …

Although interstitial lung disease (ILD) is a leading cause of morbidity and mortality in
patients with inflammatory myopathies, the current definition and diagnostic criteria of …

Many patients with an idiopathic interstitial pneumonia (IIP) have clinical features that
suggest an underlying autoimmune process but do not meet established criteria for a …

Objective To identify similarities and differences in the clinical features of adult Japanese
patients with individual anti-aminoacyl-tRNA synthetase antibodies (anti-ARS Abs). Methods …

Objective. The aim was to study the prevalence, rate of appearance and severity of clinical
features in patients with different anti-synthetase syndrome (ASyS) autoantibodies. Methods …

Anti-synthetase syndrome (ASSD) is an autoimmune disease characterized by the presence
of autoantibodies targeting one of several aminoacyl t-RNA synthetases (aaRSs) along with …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications associated
with connective tissue diseases (CTDs), resulting in significant morbidity and mortality …

Polymyositis and dermatomyositis are inflammatory myopathies that differ in their clinical
features, histopathology, response to treatment, and prognosis. Although their clinical …

Antisynthetase syndrome (ASyS) is an autoimmune disease clinically manifested most often
by interstitial lung disease, myositis, and arthritis. Raynaud's syndrome, fever, and rashes …

Autoantibodies are a hallmark in the diagnosis of many systemic autoimmune rheumatic
diseases (SARD) including idiopathic inflammatory myopathies (IIM). Based on their …